Clinical medicine profile
Diosmin (semi-synthetic)
Therapeutic agent (verify pharmacological class)
- Route
- See product SmPC
- Schedule
- POM
- ATC
- Not assigned
- PPB status
- registered
Safety essentials
The information most likely to change a prescribing or dispensing decision.
Contraindications
- CONTRAINDICATIONS: Do not use if you have a known allergy to any of the ingredients in Bruselix™ Bruising Tablets , including Arnica Montana or pineapple (Bromelain).
- Avoid use if you have an allergy to citrus or bioflavonoid components.
Precautions
- WARNINGS AND PRECAUTIONS Arnica: May cause allergic reactions in sensitive individuals, especially if there is a history of ragweed allergies.
- Bromelain: May increase the risk of bleeding in individuals taking anticoagulants or antiplatelet medications.
- Discontinue use two weeks before surgery.
- Zinc and Vitamin C: Use cautiously in individuals with kidney disease or those prone to kidney stones.
- If you experience an allergic reaction or prolonged bleeding, discontinue use and seek medical attention immediately.
- For use on the order of a licensed healthcare practitioner.
- Call your doctor about side effects.
- To report side effects, call PureTek Corporation at 1-877-921-7873.
Dosing matrix
Population and organ-function guidance, shown together for faster comparison.
DOSAGE AND ADMINISTRATION: Take one (1) Bruselix™ Bruising Tablets daily, or as directed by a licensed healthcare practitioner. Do not exceed recommended dose.
See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.
Review renal impairment dosing; many agents need CrCl/eGFR adjustment.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.
Use, effects & interactions
Indications
- INDICATIONS AND USAGE: Bruselix™ Bruising Tablets are formulated to provide nutritional support during the body’s natural recovery process.
- They may be helpful for individuals experiencing bruising due to minor injuries, surgical procedures, or sensitive skin.
- The formula contains antioxidants, enzymes, and natural extracts that are traditionally used to support overall skin health and recovery.
Adverse effects
- Adverse Reactions: Adverse reactions associated with the use of Bruising Tablets may include mild gastrointestinal discomfort, nausea, or allergic reactions such as skin rash.
- In rare cases, more serious reactions, such as prolonged bleeding or hypersensitivity reactions (e.g., difficulty breathing, swelling), may occur.
- If you experience any serious adverse effects, discontinue use and seek medical attention immediately.
Drug interactions
Open multi-drug checker ↗- Professional use: confirm indication, dose, duration, monitoring and patient counselling points against current Kenya STG / EML and the product SmPC.
- Document allergy status and key interactions.
Mechanism & disposition
Vascular protector and venotonic that acts on the return vascular system reducing venous distensibility and venous stasis.
Read complete mechanism
Vascular protector and venotonic that acts on the return vascular system reducing venous distensibility and venous stasis. It also normalizes capillary permeability besides reinforcing capillary resistance.
Product-specific
Product-specific
See product SmPC
are product-specific. Consider food effects, protein binding, hepatic CYP/UGT
when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.
Pregnancy, lactation & diet
Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.
Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.
Brands & loaded prices
| Brand | Manufacturer | Pack | Observed price |
|---|---|---|---|
| PHLEBODIA | DAIMA BIASHARA / Wholesale Import | 600MG TABS 15`S | KES 850.00afya_index_book |
Sources & review state
Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.